We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.74%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$189M
AUM Growth
+$13.3M
(+7.6%)
Cap. Flow
-$3.27M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
169
New
20
Increased
29
Reduced
82
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jacobs Solutions
J
|
+$3M |
| 2 |
Air Products & Chemicals
APD
|
+$2.21M |
| 3 |
Oracle
ORCL
|
+$1.67M |
| 4 |
Teradyne
TER
|
+$1.12M |
| 5 |
Parker-Hannifin
PH
|
+$953K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.82M |
| 2 |
Amazon
AMZN
|
+$1.48M |
| 3 |
Broadcom
AVGO
|
+$1.19M |
| 4 |
Amgen
AMGN
|
+$1.13M |
| 5 |
Starbucks
SBUX
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.74% |
| 2 | Healthcare | 18.33% |
| 3 | Technology | 16.98% |
| 4 | Consumer Staples | 11.96% |
| 5 | Consumer Discretionary | 9.75% |
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q4 2023 Portfolio in Review
As of Q4 2023, New England Research & Management held 169 positions worth $189M, up 7.6% from $175M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
New England Research & Management's Q4 2023 filing shows 20 new, 29 increased, 82 reduced and 14 closed positions. Its largest new stake was Jacobs Solutions: 27,534 shares worth $2.96M. The largest sale was UnitedHealth, an estimated $1.82M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- New England Research & Management's largest Q4 2023 buy was Jacobs Solutions: 27,534 shares worth $2.96M.
- New England Research & Management added most to Oracle in Q4 2023, an estimated $1.67M increase.
- New England Research & Management's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $1.82M.
- New England Research & Management fully exited Broadcom in Q4 2023, selling an estimated $1.19M.
- New England Research & Management's ten largest holdings make up 24% of its $189M portfolio in Q4 2023.
- New England Research & Management opened 20 new positions and closed 14 in Q4 2023.
- New England Research & Management's portfolio value rose 7.6% quarter-over-quarter to $189M.
Based on New England Research & Management's 13F filing for Q4 2023, filed 6 Feb 2024.